» Articles » PMID: 21799024

Influence of Season on Exacerbation Characteristics in Patients with COPD

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2011 Jul 30
PMID 21799024
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients with COPD experience more frequent exacerbations in the winter. However, little is known about the impact of the seasons on exacerbation characteristics.

Methods: Between November 1, 1995, and November 1, 2009, 307 patients in the London COPD cohort (196 men; age, mean, 68.1 years [SD, 8.4]; FEV(1), mean, 1.12 L [SD, 0.46]; FEV(1), mean, % predicted, 44.4% [SD, 16.1]) recorded their increase in daily symptoms and time outdoors for a median of 1,021 days (interquartile range [IQR], 631-1,576). Exacerbation was identified as ≥ 2 consecutive days with an increase in two different symptoms.

Results: There were 1,052 exacerbations in the cold seasons (November to February), of which 42.5% and 50.6% were patients who had coryzal and cough symptoms, respectively, compared with 676 exacerbations in the warm seasons (May to August), of which 31.4% and 45.4% were in patients who had coryzal and cough symptoms, respectively (P < .05). The exacerbation recovery period was longer in the cold seasons (10 days; IQR, 6-19) compared with the warm seasons (9 days; IQR, 5-16; P < .005). The decrease in outdoor activity during exacerbation, relative to a pre-exacerbation period (-14 to -8 days), was greater in the cold seasons (-0.50 h/d; IQR, -1.1 to 0) than in the warm seasons (-0.26 h/d; IQR, -0.88 to 0.18; P = .048). In the cold seasons, 8.4% of exacerbations resulted in patients who were hospitalized, compared with 4.6% of exacerbations in the warm seasons (P = .005).

Conclusions: Exacerbations are more severe between November and February. This contributes to the increased morbidity during the winter seasons.

Citing Articles

Impact of Pharmacist-Led Intervention on Adherence to Inhalers, Inhalation Technique, and Disease Control Among Asthma/COPD Patients in a Resource Limited Center: An Interventional Study.

Bhattarai A, Shakya R, Bista D Patient Prefer Adherence. 2024; 18:1395-1408.

PMID: 38974680 PMC: 11226859. DOI: 10.2147/PPA.S460810.


Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS International Study.

Athanazio R, Bernal Villada L, Avdeev S, Wang H, Ramirez-Venegas A, Sivori M BMJ Open Respir Res. 2024; 11(1).

PMID: 38637115 PMC: 11029392. DOI: 10.1136/bmjresp-2023-002101.


A cross-sectional survey on the effects of ambient temperature and humidity on health outcomes in individuals with chronic respiratory disease.

Mekhuri S, Quach S, Barakat C, Sun W, Nonoyama M Can J Respir Ther. 2023; 59:256-269.

PMID: 38084109 PMC: 10710831. DOI: 10.29390/001c.90653.


Emergency ultrasound of respiratory muscles: a promising tool for determining the outcomes of COPD exacerbations.

Yegin D, Oskay A, Oskay T, Dinc S, Senol H, Ozen M Turk J Med Sci. 2023; 53(4):1001-1011.

PMID: 38031950 PMC: 10760574. DOI: 10.55730/1300-0144.5664.


Risk Factors for Recurrent Exacerbations in the General-Practitioner-Based Swiss Chronic Obstructive Pulmonary Disease (COPD) Cohort.

Abu Hussein N, Giezendanner S, Urwyler P, Bridevaux P, Chhajed P, Geiser T J Clin Med. 2023; 12(20).

PMID: 37892832 PMC: 10606981. DOI: 10.3390/jcm12206695.